Concepedia

Barry Teobald

BT

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

1999

Affiliations

Loughborough University(Current)

AstraZeneca (United Kingdom)

Barry Teobald is an author at Loughborough University specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1999–2021

8

Publications

8

The Nicholas reaction: the use of dicobalt hexacarbonyl-stabilised propargylic cations in synthesis

Barry Teobald · Tetrahedron · 2002 · 294 citations

, , +7

Antagonists of the Platelet P<i><sub>2T</sub></i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

, , +17

From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis

Brian Springthorpe, A. S. Bailey, Patrick Barton et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 235 citations · Full text

, , +12

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Alastair Brown, Sophie J. Bradley, Fiona H. Marshall et al. · Cell · 2021 · 97 citations · Full text

, , +14

Discovery of AZD-2098 and AZD-1678, Two Potent and Bioavailable CCR4 Receptor Antagonists

Nicholas D. Kindon, Glen K. Andrews, Andrew Baxter et al. · ACS Medicinal Chemistry Letters · 2017 · 32 citations · Full text

, , +11

1–5 of 8